Wechselwirkungen · Stribild
Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets · Abschnitt 4.5 · PDF-Seite 14–15
HOS-218468 · Präparat HOS-216207
14 Medicinal product by therapeutic Effects on drug levels Recommendation concerning areas Mean percent change in AUC, Cmax, co-administration with Stribild Cmin1 GLUCOCORTICOIDS Corticosteroids Corticosteroids primarily Interaction not studied with any of the Concomitant use of Stribild and metabolised by CYP3A (including components of Stribild. corticosteroids that are metabolised betamethasone, budesonide, by CYP3A (e.g. fluticasone fluticasone, mometasone, Plasma concentrations of these propionate or other inhaled or nasal prednisone, triamcinolone). medicinal products may be increased corticosteroids) may increase the when co-administered with Stribild, risk of development of systemic resulting in reduced serum cortisol corticosteroid effects, including concentrations. Cushing’s syndrome and adrenal suppression.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
RxNorm-Namen im Text (wörtliche Treffer, Rolle nicht bewertet): triamcinolone (HOS-086333) fluticasone (HOS-108914) betamethasone (HOS-090066) budesonide (HOS-086332) mometasone (HOS-114048) propionate (HOS-108915) prednisone (HOS-084526)
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2024-07-23T16:51:00Z · SHA-256 d3f228ded6370d77784fda3a53beaff9f1155c63df0f682c7673ee3cdc2ccdc5 · Passage 22364c69256d4ace38a34d4b7613ef0d83bd1eff62c909c174a23c4a1234faf8 · Zeichen 22932–24221 im Abschnitt